David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$520M |
| 2 |
Accenture
ACN
|
+$474M |
| 3 |
Intel
INTC
|
+$436M |
| 4 |
Adobe
ADBE
|
+$318M |
| 5 |
Northrop Grumman
NOC
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Apple
AAPL
|
+$900M |
| 3 |
Microsoft
MSFT
|
+$733M |
| 4 |
Netflix
NFLX
|
+$637M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Financials | 7.13% |
| 4 | Healthcare | 6.41% |
| 5 | Industrials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Cardinal Health
CAH
$53.7B
| $30.9M | 0.03% |
313,926
+102,166
| +48% | +$10.4M |
|
|
MRUS
602
DELISTED
Merus
MRUS
| $30.8M | 0.03% |
521,339
+247,813
| +91% | +$12M |
|
603
Corcept Therapeutics
CORT
$13.1B
| $30.8M | 0.03% |
949,143
-183,941
| -16% | -$5.04M |
|
604
Kulicke & Soffa
KLIC
$4.39B
| $30.8M | 0.03% |
625,284
+313,244
| +100% | +$14.7M |
|
605
Affiliated Managers Group
AMG
$9.25B
| $30.6M | 0.03% |
195,756
-41,657
| -18% | -$6.63M |
|
606
PUT
e.l.f. Beauty
ELF
$6.08B
| $30.5M | 0.03% |
144,900
+37,600
| +35% | +$6.68M |
|
607
CALL
Marriott International
MAR
$94.4B
| $30.4M | 0.03% |
125,600
-1,700
| -1% | -$408K |
|
608
PUT
DraftKings
DKNG
$12.8B
| $30.3M | 0.03% |
795,100
-1,374,400
| -63% | -$57.1M |
|
|
NUVL
609
DELISTED
Nuvalent
NUVL
| $30.3M | 0.03% |
399,199
-46,183
| -10% | -$3.29M |
|
610
CALL
Toronto Dominion Bank
TD
$191B
| $30.2M | 0.03% |
550,000
-490,400
| -47% | -$27.8M |
|
|
RNAM
611
DELISTED
Avidity Biosciences
RNAM
| $30.2M | 0.03% |
739,039
+707,773
| +2,264% | +$20.3M |
|
612
Textron
TXT
$14.4B
| $30M | 0.03% |
349,272
-365,278
| -51% | -$32.5M |
|
613
Fluor
FLR
$6.99B
| $30M | 0.03% |
688,388
+38,847
| +6% | +$1.62M |
|
614
Alibaba
BABA
$283B
| $30M | 0.03% |
416,157
+337,313
| +428% | +$25.9M |
|
|
615
CALL
Accenture
ACN
$114B
| $29.9M | 0.03% |
98,700
+10,600
| +12% | +$3.25M |
|
|
NVO
616
CALL
Novo Nordisk
NVO
$207B
| $29.9M | 0.03% |
209,500
+186,500
| +811% | +$24.7M |
|
617
MaxLinear
MXL
$5.66B
| $29.9M | 0.03% |
1,484,324
-91,058
| -6% | -$1.79M |
|
|
JMIA
618
Jumia Technologies
JMIA
$820M
| $29.9M | 0.03% |
4,258,152
+2,230,119
| +110% | +$13.7M |
|
619
PUT
Procter & Gamble
PG
$340B
| $29.9M | 0.03% |
+181,200
| New | +$29.6M |
|
620
MongoDB
MDB
$33.3B
| $29.8M | 0.03% |
119,372
+76,338
| +177% | +$24.1M |
|
621
CALL
Rogers Communications
RCI
$19.4B
| $29.8M | 0.03% |
805,000
+465,000
| +137% | +$18M |
|
622
Norfolk Southern
NSC
$79.3B
| $29.8M | 0.03% |
138,672
+136,172
| +5,447% | +$31.6M |
|
623
CACI
CACI
$14B
| $29.6M | 0.03% |
68,758
+23,747
| +53% | +$9.7M |
|
624
CALL
Celestica
CLS
$36.2B
| $29.5M | 0.03% |
515,000
-8,900
| -2% | -$449K |
|
625
Omnicell
OMCL
$1.62B
| $29.4M | 0.03% |
1,087,834
+6,925
| +0.6% | +$201K |
|
Similar funds
David Shaw's Q2 2024 Portfolio in Review
As of Q2 2024, David Shaw held 4,975 positions worth $107B, down 8.5% from $117B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $20B in Q2 2024, closing 541 positions and reducing 1,567 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $542M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $258M.
- David Shaw's largest Q2 2024 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 2,917,600 shares worth $258M.
- David Shaw added most to Broadcom in Q2 2024, an estimated $520M increase.
- David Shaw's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $1.23B.
- David Shaw fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $542M.
- David Shaw's ten largest holdings make up 11% of its $107B portfolio in Q2 2024.
- David Shaw opened 693 new positions and closed 541 in Q2 2024.
- David Shaw's portfolio value fell 8.5% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.